Our pharmacist will assess your suitability before prescribing
These studies confirm that GLP-1s are highly effective, but their benefits diminish quickly after you stop GLP-1s
December 2025: Patients who lost their eyesight after taking Rybelsus can file claims in a newly-approved MDL No
CrossRef Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation Jieun Choi, Ye Rin Choi, Min Kyo Jeong, Hyun Ho Song, Jeong Seok Yu, Seol Hui Song, Jeong Ha Park, Min Ju Kim, Hyunjoon Park, Young Lim Ham, Sang Hak Han, Dong Joon Kim, Do Yup Lee, Ki Tae Suk Gut Microbes .2025;[Epub] CrossRef Validation of combo ichroma as a reliable concentration-based alternative for AST and ALT measurement in liver disease monitoring Minsoo Kim, Su A Kim, Jeong Min Kim, Hee Young Kim, Ho Yeong Yoon, Sung Won Park, Daegyun Park, Ji Sook Han, Ki Tae Suk Methods .2025
Consumer reviews show mixed results, with many reporting skin irritation and no weight change